Deutsche Bank Ag\ Kamada LTD Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$6.02 - $8.06 $115,981 - $155,283	-19,266 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.3 - $8.46 $121,375 - $162,990	19,266 New	19,266 $125,000
Q1 2020 May 14, 2020	SELL	$4.56 - $7.13 $10,697 - $16,726	-2,346 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.97 - $7.7 $70,852 - $109,771	-14,256 Reduced 85.87%	2,346 $16,000
Q3 2019 Nov 14, 2019	SELL	$5.11 - $5.99 $219,198 - $256,947	-42,896 Reduced 72.1%	16,602 $85,000
Q2 2019 Aug 14, 2019	SELL	$5.39 - $6.26 $84,137 - $97,718	-15,610 Reduced 20.78%	59,498 $328,000
Q1 2019 May 15, 2019	BUY	$5.12 - $6.18 $254,479 - $307,164	49,703 Added 195.64%	75,108 $430,000
Q4 2018 Feb 14, 2019	SELL	$4.68 - $6.25 $50,005 - $66,781	-10,685 Reduced 29.61%	25,405 $127,000
Q3 2018 Nov 14, 2018	BUY	$5.15 - $6.3 $106,553 - $130,347	20,690 Added 134.35%	36,090 $223,000
Q2 2018 Aug 14, 2018	BUY	$4.4 - $5.3 $67,760 - $81,620	15,400 New	15,400 $80,000
Q1 2018 May 15, 2018	SELL	$4.6 - $5.75 $51,979 - $64,975	-11,300 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.35 - $5.15 $173,791 - $205,752	-39,952 Reduced 77.95%	11,300 $53,000
Q3 2017 Nov 14, 2017	BUY	$4.25 - $4.8 $217,821 - $246,009	51,252	51,252 $246,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.